Biotechnology VALUE FUND L P, Insider at FIVE PRIME THERAPEUTICS, INC. (FPRX), sold 14,786,680 shares at $20.19 ($298.5M) on 2020-11-11, disclosed to the SEC on 2020-11-13.
Open-market sale of $298.5M FPRX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.19 | 502,649 | $10.1M | 3.4% |
| 2 | $20.19 | 502,649 | $10.1M | 3.4% |
| 3 | $20.19 | 2,949,477 | $59.5M | 19.9% |
| 4 | $20.19 | 2,949,477 | $59.5M | 19.9% |
| 5 | $20.19 | 3,941,214 | $79.6M | 26.7% |
| 6 | $20.19 | 3,941,214 |
| $79.6M |
| 26.7% |
| Total | $20.19 avg | 14,786,680 | $298.5M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |